Shire, Swedish Orphan Biovitrum sales and marketing update

Swedish Orphan said Shire plans to regain marketing and distribution rights to Xagrid anagrelide to treat thrombocytopenia, Fosrenol lanthanum carbonate to manage and treat hyperphosphatemia and ADH...